The identification of therapeutic targets involves understanding the molecular and genetic basis of cancer. Techniques such as gene expression profiling, genome-wide association studies (GWAS), and functional genomics are used to identify genes or pathways that are altered in cancer cells. Once identified, these targets can be validated using preclinical models before progressing to clinical trials.
